COR Q2 2020 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$68B

Q2 2020 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$47.4B+9.5% YoY

Gross Profit

$1.3B2.7% margin

Operating Income

$601M1.3% margin

Net Income

$960M2.0% margin

EPS (Diluted)

$4.64

QoQ Revenue Growth

-0.9%

Cash Flow

Operating Cash Flow

$853M

Free Cash Flow

$776M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$42.0B

Total Liabilities

$38.3B

Stockholders' Equity

$3.6B

Cash & Equivalents

$3.7B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$47.4B	$43.3B	+9.5%
Gross Profit	$1.3B	$1.2B	+3.6%
Operating Income	$601M	$621M	-3.2%
Net Income	$960M	$27M	+3438.9%

Revenue Segments

Pharmaceutical Distribution

$45.6B96%

Other Segments

$1.9B4%

Geographic Segments

Other Segments

$1.9B100%